If pancreatitis is suspected, Wegovy should be discontinued and appropriate diagnostic tests performed urgently Gallbladder problems : Rapid weight loss increases risk of gallstone formation, with cholelithiasis reported in approximately 1.6% of Wegovy users Intestinal obstruction/ileus : Cases have been reported in post-marketing surveillance, particularly in patients with pre-existing GI conditions Management strategies recommended by healthcare professionals include: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, spicy, or heavily processed foods Staying well-hydrated, particularly if experiencing diarrhoea or vomiting, to prevent dehydration and potential acute kidney injury Not lying down immediately after eating to minimise reflux Ensuring adequate fibre intake to prevent constipation Taking the medication on the same day each week to maintain steady levels Most GI side effects improve over time as the body adjusts to the medication, typically becoming less troublesome after 4-8 weeks at each dose level
Clin Med Insights Endocrinol Diabetes 15:11795514221086634
Some compounding pharmacies offer lower-cost versions of these medications, but the FDA has issued safety warnings about compounded GLP-1 products
Both approaches produce modest effects compared to actual GLP-1 medications
In brief, a stepwise filtering approach was implemented in each subclass dataset [44]
Brain Behav Immun 87:901909 Poljsak B, uput D, Milisav I (2013) Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants
/assets/images/provider/photos/2813769.png)
